Child Health News

RSS

Toddlers and obese children suffer more than youth when exposed to secondhand smoke

Toddlers and obese children suffer more than other youth when exposed to secondhand smoke, according to research presented at the American Heart Association's Scientific Sessions 2009.

19 Nov 2009

FDA Advisory Committee votes in support of Pfizer's Prevnar 13

Pfizer Inc announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee voted 10 to 1 that the data presented support the safety and effectiveness of its 13-valent pneumococcal conjugate candidate vaccine, Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), for the prevention of invasive pneumococcal disease in infants and young children.

19 Nov 2009

Baby's sleep position can predict misshapen skull condition

A baby's sleep position is the best predictor of a misshapen skull condition known as deformational plagiocephaly - or the development of flat spots on an infant's head - according to findings reported by Arizona State University scientists in the December issue of the journal Pediatrics.

18 Nov 2009

AT&T supports PADRES Contra El Cancer in campaign to raise awareness of childhood cancer

AT&T* today announced that it will launch the fourth annual campaign to raise awareness of childhood cancer and collect donations to support PADRES Contra El Cancer (PADRES), a nonprofit organization committed to improving the quality of life for Latino children who are battling the disease, beginning November 22. AT&T set a goal of raising $300,000 this year, which would mean a total donation of $1 million to PADRES since the campaign's inception in 2007.

18 Nov 2009

Pentavalent price drops: the GAVI effect

Following the increasing impact of the GAVI Alliance on the vaccine market, the price of one of the major combination vaccines, the pentavalent, is falling considerably, enabling GAVI’s partners to vaccinate millions of more children in the developing world.

18 Nov 2009

Childhood obesity in Ohio: Healthy Choices for Healthy Children legislation introduced

A bi-partisan effort to decrease and prevent childhood obesity was introduced today in the Ohio Senate and Ohio House of Representatives, with the strong support of the Healthy Choices for Healthy Children coalition. The Healthy Choices for Healthy Children legislation is co-sponsored by Senator Kevin Coughlin (R-Cuyahoga Falls) and Senator Eric H. Kearney (D-Cincinnati) in the Ohio Senate.

18 Nov 2009

Majority of mothers personally manage their children's health this coming winter

Three out of four mothers with a child between the ages of two through 12 are extremely, very, or somewhat concerned about their child's health this coming winter, according to a survey conducted by Opinion Research Corporation and commissioned by Bionorica, an international company pioneering clinical research of natural remedies including Sinupret® for Kids, a product which supports healthy respiratory function in children (www.bionoricausa.com).

18 Nov 2009

Pediatric data for Pfizer's Lipitor submitted to the EMEA

Pfizer Inc announced it has submitted pediatric data for Lipitor® (atorvastatin) to the European Medicines Agency (EMEA). Pfizer has also developed a new chewable form of Lipitor, including a pediatric-appropriate 5 mg dose, which is part of this submission.

18 Nov 2009

New study reveals certain prescription drugs can be harmful to fetus

More than six percent of expectant mothers in Quebec consume prescription drugs that are known to be harmful to their fetuses, according to a Universit- de Montr-al investigation published in the British Journal of Obstetrics and Gynaecology

18 Nov 2009

Sildenafil improves heart function in youngsters with single ventricle congenital heart disease

Heart function significantly improved in children and young adults with single ventricle congenital heart disease who have had the Fontan operation following treatment with sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, say researchers from The Children's Hospital of Philadelphia.

18 Nov 2009

CTSA institutions receive NIH grants to study drug safety and efficacy in children

Studying drugs in pediatric populations is challenging because drugs often affect children differently than they do adults. The scarcity of pediatric studies limits the ability of doctors and scientists to predict drug dosing, safety and efficacy in children. To address this gap, the National Institutes of Health announced today 18 grants to help determine outcome measures and increase the likelihood of success of future trials of treatments for children.

18 Nov 2009

Report calls for refocusing health spending in developing countries to save children's lives

"More than 24,000 infants die daily from preventable diseases in developing countries," and child deaths have fallen in countries where governments "have shown a high level of political leadership on child health," World Vision International said in a new report (.pdf) released on Monday as part of a five-year campaign to reduce child deaths worldwide, the Associated Press/San Francisco Chronicle reports.

17 Nov 2009

Consortium to define new modalities for treating hypertension and associated vascular complications

Top Institute Pharma has formed a consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and Maastricht University to define new modalities for the treatment of hypertension (high blood pressure) and associated vascular complications such as heart and kidney failure, myocardial infarction and stroke.

17 Nov 2009

U.S. again scores 'D' for premature birth rate; states take action to reduce risk factors

For the second consecutive year, the United States earned only a "D" on the March of Dimes Premature Birth Report Card, demonstrating that more than half a million of our nation's newborns didn't get the healthy start they deserved.

17 Nov 2009

Shire publishes new study results on INTUNIV Extended-Release Tablets

Shire plc, the global specialty biopharmaceutical company, announced new study results on INTUNIV- (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology. In this open-label safety study, there was no evidence of unique adverse effects with the combination of INTUNIV and amphetamine or methylphenidate relative to what was observed with either medication alone.

17 Nov 2009

Colorado receives “D” on Premature Birth Report Card for the second consecutive year

For the second consecutive year, Colorado received a “D” on the Premature Birth Report Card issued by the March of Dimes. However, the state did show improvement in two key areas that affect prematurity, including the rate of smoking for childbearing-age women.

17 Nov 2009

Patients with pediatric-onset MS develop disabilities at a slower pace than patients with adult-onset MS: Study

Magnetic resonance images (MRI) of patients diagnosed with multiple sclerosis in childhood show that pediatric onset multiple sclerosis is more aggressive, and causes more brain lesions, than MS diagnosed in adulthood, researchers at the University at Buffalo have reported.

17 Nov 2009

Food allergies among children is increasing: Study

A newly published article provides further evidence that the prevalence of food allergies among children is increasing. The article, "Food Allergy Among Children in the United States" appears in the December issue of Pediatrics, a US medical journal.

17 Nov 2009

Fetal exposure to phthalates has the potential to alter masculine brain development: Study

A study of 145 preschool children reports, for the first time, that when the concentrations of two common phthalates in mothers' prenatal urine are elevated their sons are less likely to play with male-typical toys and games, such as trucks and play fighting.

16 Nov 2009

Findings from post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse announced

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse-. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 to 12 years.

16 Nov 2009

Child Health News

Toddlers and obese children suffer more than youth when exposed to secondhand smoke

FDA Advisory Committee votes in support of Pfizer's Prevnar 13

Baby's sleep position can predict misshapen skull condition

AT&T supports PADRES Contra El Cancer in campaign to raise awareness of childhood cancer

Pentavalent price drops: the GAVI effect

Childhood obesity in Ohio: Healthy Choices for Healthy Children legislation introduced

Majority of mothers personally manage their children's health this coming winter

Pediatric data for Pfizer's Lipitor submitted to the EMEA

New study reveals certain prescription drugs can be harmful to fetus

Sildenafil improves heart function in youngsters with single ventricle congenital heart disease

CTSA institutions receive NIH grants to study drug safety and efficacy in children

Report calls for refocusing health spending in developing countries to save children's lives

Consortium to define new modalities for treating hypertension and associated vascular complications

U.S. again scores 'D' for premature birth rate; states take action to reduce risk factors

Shire publishes new study results on INTUNIV Extended-Release Tablets

Colorado receives “D” on Premature Birth Report Card for the second consecutive year

Patients with pediatric-onset MS develop disabilities at a slower pace than patients with adult-onset MS: Study

Food allergies among children is increasing: Study

Fetal exposure to phthalates has the potential to alter masculine brain development: Study

Findings from post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse announced

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News